India · Delayed Price · Currency is INR Deccan Health Care Statistics
Total Valuation
BOM:542248 has a market cap or net worth of INR 299.85 million. The enterprise value is 322.81 million.
| Market Cap | 299.85M |
| Enterprise Value | 322.81M |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:542248 has 23.43 million shares outstanding. The number of shares has decreased by -4.35% in one year.
| Current Share Class | 23.43M |
| Shares Outstanding | 23.43M |
| Shares Change (YoY) | -4.35% |
| Shares Change (QoQ) | -2.43% |
| Owned by Insiders (%) | 43.13% |
| Owned by Institutions (%) | n/a |
| Float | 7.21M |
Valuation Ratios
The trailing PE ratio is 12.67.
| PE Ratio | 12.67 |
| Forward PE | n/a |
| PS Ratio | 0.37 |
| PB Ratio | 0.27 |
| P/TBV Ratio | 0.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.98 |
| EV / Sales | 0.39 |
| EV / EBITDA | 6.35 |
| EV / EBIT | 8.91 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.04.
| Current Ratio | 3.81 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | -0.64 |
| Interest Coverage | 9.89 |
Financial Efficiency
Return on equity (ROE) is 2.30% and return on invested capital (ROIC) is 2.49%.
| Return on Equity (ROE) | 2.30% |
| Return on Assets (ROA) | 1.65% |
| Return on Invested Capital (ROIC) | 2.49% |
| Return on Capital Employed (ROCE) | 3.15% |
| Weighted Average Cost of Capital (WACC) | 7.23% |
| Revenue Per Employee | 9.87M |
| Profits Per Employee | 299,711 |
| Employee Count | 83 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 1.12 |
Taxes
In the past 12 months, BOM:542248 has paid 7.78 million in taxes.
| Income Tax | 7.78M |
| Effective Tax Rate | 23.83% |
Stock Price Statistics
The stock price has decreased by -34.85% in the last 52 weeks. The beta is 0.55, so BOM:542248's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -34.85% |
| 50-Day Moving Average | 12.74 |
| 200-Day Moving Average | 14.18 |
| Relative Strength Index (RSI) | 56.72 |
| Average Volume (20 Days) | 7,720 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:542248 had revenue of INR 819.05 million and earned 24.88 million in profits. Earnings per share was 1.01.
| Revenue | 819.05M |
| Gross Profit | 315.23M |
| Operating Income | 36.23M |
| Pretax Income | 32.66M |
| Net Income | 24.88M |
| EBITDA | 50.87M |
| EBIT | 36.23M |
| Earnings Per Share (EPS) | 1.01 |
Balance Sheet
The company has 16.66 million in cash and 39.62 million in debt, with a net cash position of -22.97 million or -0.98 per share.
| Cash & Cash Equivalents | 16.66M |
| Total Debt | 39.62M |
| Net Cash | -22.97M |
| Net Cash Per Share | -0.98 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 46.22 |
| Working Capital | 956.83M |
Cash Flow
In the last 12 months, operating cash flow was -36.21 million and capital expenditures -25.67 million, giving a free cash flow of -61.89 million.
| Operating Cash Flow | -36.21M |
| Capital Expenditures | -25.67M |
| Depreciation & Amortization | 14.64M |
| Net Borrowing | 28.17M |
| Free Cash Flow | -61.89M |
| FCF Per Share | -2.64 |
Margins
Gross margin is 38.49%, with operating and profit margins of 4.42% and 3.04%.
| Gross Margin | 38.49% |
| Operating Margin | 4.42% |
| Pretax Margin | 3.99% |
| Profit Margin | 3.04% |
| EBITDA Margin | 6.21% |
| EBIT Margin | 4.42% |
| FCF Margin | n/a |
Dividends & Yields
BOM:542248 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.35% |
| Shareholder Yield | 4.35% |
| Earnings Yield | 8.30% |
| FCF Yield | -20.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |